Mechanisms of Angiogenesis

Is it advisable to go back from bedside to the bench? During the last decade, few topics encountered such a broad interest in bio- gy and medicine as angiogenesis. The amazing ability of the body to restore blood flow by induction of blood vessel growth as part of an adaptive process has alarmed phy...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Clauss, Matthias (Επιμελητής έκδοσης), Breier, Georg (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Basel : Birkhäuser Basel, 2005.
Σειρά:Experientia Supplementum
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04150nam a22005055i 4500
001 978-3-7643-7311-5
003 DE-He213
005 20151204154615.0
007 cr nn 008mamaa
008 100301s2005 sz | s |||| 0|eng d
020 |a 9783764373115  |9 978-3-7643-7311-5 
024 7 |a 10.1007/b137088  |2 doi 
040 |d GrThAP 
050 4 |a R-RZ 
072 7 |a MBGR  |2 bicssc 
072 7 |a MED000000  |2 bisacsh 
082 0 4 |a 610  |2 23 
245 1 0 |a Mechanisms of Angiogenesis  |h [electronic resource] /  |c edited by Matthias Clauss, Georg Breier. 
264 1 |a Basel :  |b Birkhäuser Basel,  |c 2005. 
300 |a XIV, 324 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Experientia Supplementum 
505 0 |a Basic principles in physiological and pathophysiological angiogenesis -- How do endothelial cells orientate? -- New insights into intussusceptive angiogenesis -- Angiogenesis in the female reproductive system -- Arterialization, coronariogenesis and arteriogenesis -- Sprouting angiogenesis versus co-option in tumor angiogenesis -- Hormones and the neovascularization process: role of angiotensin II -- Can tumor angiogenesis be inhibited without resistance? -- Cellular and physical mechanisms of blood vessel growth -- Role of pericytes in vascular morphogenesis -- Role of monocytes and macrophages in angiogenesis -- Bone marrow-derived endothelial progenitor cells for neovascular formation -- Can angiogenesis be exercised? -- Angiogenesis — a self-adapting principle in hypoxia -- Cellular mechanisms of arteriogenesis -- Balancing luminal size and smooth muscle proliferation — a key control point in atherosclerosis and arteriogenesis -- Molecular mechanisms of angiogenesis -- The role of VEGF in the regulation of physiological and pathological angiogenesis -- The anti-inflammatory actions of angiopoietin-1 -- The hemostatic system in angiogenesis -- Signal transduction in angiogenesis. 
520 |a Is it advisable to go back from bedside to the bench? During the last decade, few topics encountered such a broad interest in bio- gy and medicine as angiogenesis. The amazing ability of the body to restore blood flow by induction of blood vessel growth as part of an adaptive process has alarmed physicians dealing with diseases in which angiogenesis is either exaggerated (as in tumors) or too slow (as in ischemic diseases of heart and brain). Not surprisingly, pro- and antiangiogenic strategies have found their way into clinical trials. For instance, for the USA, the NIH website in early 2004 displayed 38 clinical studies involving either pro- or antiangiogenic th- apies. Given the expected overwhelming wealth of clinical data, the question may be asked whether further exploration of biological mechanisms is required or whether results from the bedside are instructive enough to proceed. This question depends also on the progress of pro- and antiangiogenic clinical trials. In the following, I give a short overview about some of the progress that has been made in this field. Since Judah Folkman proposed antiangiogenic tumor therapy thirty years ago, it has become increasingly evident that agents which interfere with blood vessel formation also block tumor progression. Accordingly, antiangiogenic therapy has gained much attention as a potential adjunct to conventional c- cer therapy. 
650 0 |a Medicine. 
650 0 |a Cancer research. 
650 0 |a Molecular biology. 
650 0 |a Angiology. 
650 1 4 |a Biomedicine. 
650 2 4 |a Biomedicine general. 
650 2 4 |a Cancer Research. 
650 2 4 |a Molecular Medicine. 
650 2 4 |a Angiology. 
700 1 |a Clauss, Matthias.  |e editor. 
700 1 |a Breier, Georg.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783764364595 
830 0 |a Experientia Supplementum 
856 4 0 |u http://dx.doi.org/10.1007/b137088  |z Full Text via HEAL-Link 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642)